Exclusive Live Interviews with Biotech Executives from GEN EDGE

Exclusive_Live_Interviews
In this Close to the Edge new live series, we’ll be interviewing chief executives and scientific and business leaders from the biotech spectrum. In this inaugural episode on May 12 GEN Edge welcomes Christian Henry, the CEO of PacBio, for an exclusive interview.
Watch Now

Spotlight

OTHER ON-DEMAND WEBINARS

Approval, Commercialization Highlighted at Cell & Gene Meeting on the Mesa

The annual Cell & Gene Meeting on the Mesa in San Diego kicked off this week with a packed schedule of sessions and some 40 company presentations that speak to the significant progress in these burgeoning therapeutic fields.
Watch Now

The Rising Demand for Trust & Transparency: Blockchain for Food

IBM

The global food system is growing rapidly, contributing to the abundance of choices available for consumers and adding complexity to the food supply chain. With numerous connection points and so many participants, there are greater chances for inefficiency, waste, and fraud. Consequently, innovators in the food industry are now recognizing the opportunity to modernize and transform the food system, creating greater trust and transparency throughout. Using Blockchain as the underlying technology for a renewed food system, organizations are realizing unique benefits that accompany the digitization of information. In addition to gaining abilities like instant tracebacks, supply chain efficiency and data insights, participants are acquiring brand differentiation, consumer trust, and sustainability.
Watch Now

Comprehensive analysis of next generation biologics using advanced data interpretation software

labroots.com

Protein therapeutics is one of the major drug modalities in the biopharma industry. With more and more elucidation of disease pathology, the development of next generation protein therapeutics has become the trend of protein therapeutics development. Unfortunately, these next generation biologics (NGBs) such as fusion proteins exhibit additional levels of complexity beyond regular monoclonal antibody therapeutics.
Watch Now

It’s Never Too Late: Improve Clinical Trial Processes with a Unified Platform

Veeva

As scientific innovation has led to new trial designs, modern cloud technologies have enabled the industry to better manage how clinical trials are executed. Newer, more advanced cloud applications now offer unified data and process models, allowing organizations to manage their end-to-end clinical trial process within a single system. Rather than juggling individual point solutions, innovative organizations are using a unified clinical platform for greater efficiency, quality, and speed of execution. Join Veeva and Idorsia to learn how your organization can leverage a unified clinical operating model and drive new levels of efficiency across the entire clinical ecosystem.
Watch Now

Spotlight

resources